

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.67762527 |
| 2 | central nervous system myelination (GO:0022010) | 5.67762527 |
| 3 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.22072585 |
| 4 | fatty acid elongation (GO:0030497) | 4.58804642 |
| 5 | myelination (GO:0042552) | 4.20460712 |
| 6 | ensheathment of neurons (GO:0007272) | 4.19800280 |
| 7 | axon ensheathment (GO:0008366) | 4.19800280 |
| 8 | negative regulation of neurotransmitter transport (GO:0051589) | 4.14679718 |
| 9 | presynaptic membrane assembly (GO:0097105) | 3.95507587 |
| 10 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.92321924 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 3.88347657 |
| 12 | sodium ion export (GO:0071436) | 3.85959702 |
| 13 | presynaptic membrane organization (GO:0097090) | 3.62924047 |
| 14 | ER overload response (GO:0006983) | 3.40514812 |
| 15 | response to redox state (GO:0051775) | 3.35399645 |
| 16 | response to hepatocyte growth factor (GO:0035728) | 3.26030502 |
| 17 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.26030502 |
| 18 | glutamate secretion (GO:0014047) | 3.22055639 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.21473308 |
| 20 | Rap protein signal transduction (GO:0032486) | 3.15588506 |
| 21 | neuronal action potential propagation (GO:0019227) | 3.12995592 |
| 22 | oligodendrocyte differentiation (GO:0048709) | 3.09523811 |
| 23 | substantia nigra development (GO:0021762) | 3.09507584 |
| 24 | regulation of collateral sprouting (GO:0048670) | 3.08858319 |
| 25 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.08432798 |
| 26 | L-amino acid import (GO:0043092) | 3.07867276 |
| 27 | glycerophospholipid catabolic process (GO:0046475) | 3.05540316 |
| 28 | cholesterol biosynthetic process (GO:0006695) | 3.03724910 |
| 29 | photoreceptor cell differentiation (GO:0046530) | 3.01578367 |
| 30 | eye photoreceptor cell differentiation (GO:0001754) | 3.01578367 |
| 31 | transmission of nerve impulse (GO:0019226) | 3.01262209 |
| 32 | positive regulation of action potential (GO:0045760) | 3.00958292 |
| 33 | adhesion of symbiont to host cell (GO:0044650) | 2.96752061 |
| 34 | virion attachment to host cell (GO:0019062) | 2.96752061 |
| 35 | phagosome maturation (GO:0090382) | 2.92385473 |
| 36 | synaptic vesicle maturation (GO:0016188) | 2.91667877 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 2.90124052 |
| 38 | regulation of ARF protein signal transduction (GO:0032012) | 2.89647982 |
| 39 | response to lipoprotein particle (GO:0055094) | 2.88605447 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.86984998 |
| 41 | neuron cell-cell adhesion (GO:0007158) | 2.86299849 |
| 42 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.78933316 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.77578604 |
| 44 | nucleotide transmembrane transport (GO:1901679) | 2.75174958 |
| 45 | magnesium ion transport (GO:0015693) | 2.74019026 |
| 46 | potassium ion import (GO:0010107) | 2.72789506 |
| 47 | macroautophagy (GO:0016236) | 2.72495084 |
| 48 | transferrin transport (GO:0033572) | 2.72338023 |
| 49 | sterol biosynthetic process (GO:0016126) | 2.67490389 |
| 50 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.67209548 |
| 51 | negative regulation of exocytosis (GO:0045920) | 2.66845536 |
| 52 | myelination in peripheral nervous system (GO:0022011) | 2.66416022 |
| 53 | peripheral nervous system axon ensheathment (GO:0032292) | 2.66416022 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65745506 |
| 55 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.65133118 |
| 56 | cellular sodium ion homeostasis (GO:0006883) | 2.65097724 |
| 57 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.64990313 |
| 58 | glycosylceramide metabolic process (GO:0006677) | 2.64628617 |
| 59 | myelin maintenance (GO:0043217) | 2.62727132 |
| 60 | nerve growth factor signaling pathway (GO:0038180) | 2.62582168 |
| 61 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.60648909 |
| 62 | asymmetric protein localization (GO:0008105) | 2.60151882 |
| 63 | ferric iron transport (GO:0015682) | 2.59701515 |
| 64 | trivalent inorganic cation transport (GO:0072512) | 2.59701515 |
| 65 | amino acid import (GO:0043090) | 2.59161432 |
| 66 | cellular response to epinephrine stimulus (GO:0071872) | 2.57048637 |
| 67 | apical protein localization (GO:0045176) | 2.56397156 |
| 68 | potassium ion homeostasis (GO:0055075) | 2.55592393 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54525624 |
| 70 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.52385743 |
| 71 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.52304393 |
| 72 | peripheral nervous system development (GO:0007422) | 2.51894407 |
| 73 | negative regulation of protein localization to cell surface (GO:2000009) | 2.50820507 |
| 74 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.50379787 |
| 75 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.50379787 |
| 76 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.47866703 |
| 77 | amyloid precursor protein metabolic process (GO:0042982) | 2.47286204 |
| 78 | Golgi to plasma membrane protein transport (GO:0043001) | 2.46859575 |
| 79 | signal peptide processing (GO:0006465) | 2.46183852 |
| 80 | detection of calcium ion (GO:0005513) | 2.44303681 |
| 81 | isoprenoid biosynthetic process (GO:0008299) | 2.43858190 |
| 82 | cell communication by electrical coupling (GO:0010644) | 2.43517877 |
| 83 | pH reduction (GO:0045851) | 2.43090500 |
| 84 | response to epinephrine (GO:0071871) | 2.43013553 |
| 85 | cyclic nucleotide catabolic process (GO:0009214) | 2.41869802 |
| 86 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.41016271 |
| 87 | cerebellar granule cell differentiation (GO:0021707) | 2.40610495 |
| 88 | amyloid precursor protein catabolic process (GO:0042987) | 2.40084334 |
| 89 | adult walking behavior (GO:0007628) | 2.40043473 |
| 90 | negative regulation of inclusion body assembly (GO:0090084) | 2.38860964 |
| 91 | intracellular pH reduction (GO:0051452) | 2.38325763 |
| 92 | creatine metabolic process (GO:0006600) | 2.38324420 |
| 93 | neuron remodeling (GO:0016322) | 2.37948575 |
| 94 | import into cell (GO:0098657) | 2.36705478 |
| 95 | membrane assembly (GO:0071709) | 2.35845308 |
| 96 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.35683845 |
| 97 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.35000006 |
| 98 | mating behavior (GO:0007617) | 2.34452015 |
| 99 | neuronal ion channel clustering (GO:0045161) | 2.33438772 |
| 100 | negative regulation of JUN kinase activity (GO:0043508) | 2.33151341 |
| 101 | neurotransmitter secretion (GO:0007269) | 2.32890439 |
| 102 | protein localization to endosome (GO:0036010) | 2.30917860 |
| 103 | regulation of beta-amyloid formation (GO:1902003) | 2.30565907 |
| 104 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.29841852 |
| 105 | response to monoamine (GO:0071867) | 2.28790052 |
| 106 | response to catecholamine (GO:0071869) | 2.28790052 |
| 107 | cellular response to catecholamine stimulus (GO:0071870) | 2.28019665 |
| 108 | cellular response to monoamine stimulus (GO:0071868) | 2.28019665 |
| 109 | locomotory exploration behavior (GO:0035641) | 2.27771358 |
| 110 | negative regulation of synaptic transmission (GO:0050805) | 2.27633179 |
| 111 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.27583064 |
| 112 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.27511413 |
| 113 | negative regulation of axonogenesis (GO:0050771) | 2.26299629 |
| 114 | long-term synaptic potentiation (GO:0060291) | 2.25094262 |
| 115 | regulation of synaptic vesicle transport (GO:1902803) | 2.24166431 |
| 116 | astrocyte development (GO:0014002) | 2.23866489 |
| 117 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.23406958 |
| 118 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.21629250 |
| 119 | synaptic vesicle exocytosis (GO:0016079) | 2.21595796 |
| 120 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.20387653 |
| 121 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.16069133 |
| 122 | adhesion of symbiont to host (GO:0044406) | 2.15297027 |
| 123 | regulation of synaptic plasticity (GO:0048167) | 2.15109472 |
| 124 | activated T cell proliferation (GO:0050798) | 2.15034335 |
| 125 | eosinophil chemotaxis (GO:0048245) | 2.14993552 |
| 126 | regulation of cell communication by electrical coupling (GO:0010649) | 2.13709925 |
| 127 | glutamate receptor signaling pathway (GO:0007215) | 2.12613560 |
| 128 | positive regulation of amino acid transport (GO:0051957) | 2.08491978 |
| 129 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.08342269 |
| 130 | long-term memory (GO:0007616) | 2.06501382 |
| 131 | neural nucleus development (GO:0048857) | 2.06172950 |
| 132 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.05795083 |
| 133 | vocalization behavior (GO:0071625) | 2.05741739 |
| 134 | astrocyte differentiation (GO:0048708) | 2.05236705 |
| 135 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.02999596 |
| 136 | response to methylmercury (GO:0051597) | 2.02978559 |
| 137 | neuron projection regeneration (GO:0031102) | 2.02145620 |
| 138 | intestinal epithelial cell development (GO:0060576) | 2.01110327 |
| 139 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 1.98483431 |
| 140 | exploration behavior (GO:0035640) | 1.96861948 |
| 141 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 1.96835083 |
| 142 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 1.96817422 |
| 143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 1.96420335 |
| 144 | regulation of neurotransmitter secretion (GO:0046928) | 1.96249973 |
| 145 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 1.95865143 |
| 146 | regulation of early endosome to late endosome transport (GO:2000641) | 1.95606095 |
| 147 | regulation of Rac protein signal transduction (GO:0035020) | 1.94835053 |
| 148 | neuromuscular process controlling balance (GO:0050885) | 1.94773475 |
| 149 | clathrin coat assembly (GO:0048268) | 1.93609614 |
| 150 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 1.92590498 |
| 151 | positive regulation of glucose import (GO:0046326) | 1.91646852 |
| 152 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.90658418 |
| 153 | response to parathyroid hormone (GO:0071107) | 1.90558437 |
| 154 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.90552066 |
| 155 | cell communication involved in cardiac conduction (GO:0086065) | 1.90387553 |
| 156 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 1.90042614 |
| 157 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 1.89585224 |
| 158 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 1.88976081 |
| 159 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.88337130 |
| 160 | dopamine receptor signaling pathway (GO:0007212) | 1.87816407 |
| 161 | suckling behavior (GO:0001967) | 1.87794732 |
| 162 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.87427731 |
| 163 | relaxation of cardiac muscle (GO:0055119) | 1.87186121 |
| 164 | regulation of NFAT protein import into nucleus (GO:0051532) | 1.86274897 |
| 165 | postsynaptic membrane organization (GO:0001941) | 1.86121149 |
| 166 | activation of protein kinase A activity (GO:0034199) | 1.85754377 |
| 167 | regulation of neurotransmitter transport (GO:0051588) | 1.85396620 |
| 168 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.85182229 |
| 169 | multicellular organismal water homeostasis (GO:0050891) | 1.84274877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.57593120 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.01836611 |
| 3 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.47259184 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.36115230 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32165667 |
| 6 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.17320224 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10987457 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06198916 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96450667 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95651201 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.93838204 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81999704 |
| 13 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.81997386 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.81817766 |
| 15 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78319425 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77915258 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74051204 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73380681 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70097104 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69510196 |
| 21 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65985444 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.65877271 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63256745 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63134075 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63048124 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61085263 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59787999 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.59258984 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.59015439 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51793477 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48685903 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.48401048 |
| 33 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.45790105 |
| 34 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45739602 |
| 35 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45739602 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.45739121 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43855479 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.43661964 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43013631 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40893178 |
| 41 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40861116 |
| 42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40827695 |
| 43 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40246331 |
| 44 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38557626 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.37963965 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37343094 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37285945 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36956993 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36818528 |
| 50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36385084 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36385084 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35117566 |
| 53 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33981425 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.33887161 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32913373 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32183556 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31804519 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31506931 |
| 59 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31310587 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30332181 |
| 61 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30271257 |
| 62 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26863062 |
| 63 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26640227 |
| 64 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26496320 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26316263 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25617714 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23572110 |
| 68 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22946378 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22066142 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21429823 |
| 71 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.20965608 |
| 72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20938678 |
| 73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20806393 |
| 74 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20070833 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19945729 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18721315 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17476638 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17241624 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17196127 |
| 80 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16912591 |
| 81 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.15879724 |
| 82 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15546958 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15298198 |
| 84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15285450 |
| 85 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14666600 |
| 86 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.14313066 |
| 87 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13764726 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10765807 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10072089 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09770954 |
| 91 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09371465 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08753893 |
| 93 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.08584677 |
| 94 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.07911838 |
| 95 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07072627 |
| 96 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06848025 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06360312 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06358455 |
| 99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06020165 |
| 100 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.05549054 |
| 101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.04856799 |
| 102 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04716692 |
| 103 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04564262 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03434599 |
| 105 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03243011 |
| 106 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02972172 |
| 107 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02951107 |
| 108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02829775 |
| 109 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02521565 |
| 110 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02111761 |
| 111 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01523267 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01105797 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00916345 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00833056 |
| 115 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00637171 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00444017 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00346824 |
| 118 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00090459 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99828171 |
| 120 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98581422 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98447987 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97763063 |
| 123 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97469660 |
| 124 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.97266029 |
| 125 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.97126140 |
| 126 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95775708 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95688444 |
| 128 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95684783 |
| 129 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94690658 |
| 130 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94477733 |
| 131 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92298450 |
| 132 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92244879 |
| 133 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91583255 |
| 134 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91096231 |
| 135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89977308 |
| 136 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.88911691 |
| 137 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88714196 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88442625 |
| 139 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87557541 |
| 140 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86466191 |
| 141 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85642751 |
| 142 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85642751 |
| 143 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85442047 |
| 144 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85183593 |
| 145 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84717027 |
| 146 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84706422 |
| 147 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84650786 |
| 148 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84141458 |
| 149 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83953185 |
| 150 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83490471 |
| 151 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82367714 |
| 152 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81788530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.86717691 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.65929820 |
| 3 | MP0003880_abnormal_central_pattern | 3.26310459 |
| 4 | MP0004270_analgesia | 3.23017228 |
| 5 | MP0003690_abnormal_glial_cell | 3.12660039 |
| 6 | MP0005171_absent_coat_pigmentation | 2.99700207 |
| 7 | MP0002272_abnormal_nervous_system | 2.42130537 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.40754590 |
| 9 | MP0002064_seizures | 2.37731002 |
| 10 | MP0009046_muscle_twitch | 2.21343735 |
| 11 | MP0003195_calcinosis | 2.18056091 |
| 12 | MP0009745_abnormal_behavioral_response | 2.12787876 |
| 13 | MP0001486_abnormal_startle_reflex | 2.09659798 |
| 14 | MP0004742_abnormal_vestibular_system | 2.09246268 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.01736165 |
| 16 | MP0001958_emphysema | 1.99962974 |
| 17 | MP0004043_abnormal_pH_regulation | 1.98457739 |
| 18 | MP0003634_abnormal_glial_cell | 1.98363089 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 1.97330756 |
| 20 | MP0003136_yellow_coat_color | 1.96792182 |
| 21 | MP0001905_abnormal_dopamine_level | 1.95209033 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 1.94796469 |
| 23 | MP0004885_abnormal_endolymph | 1.92704730 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 1.92530264 |
| 25 | MP0001529_abnormal_vocalization | 1.92345245 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.91320857 |
| 27 | MP0001986_abnormal_taste_sensitivity | 1.89442942 |
| 28 | MP0002822_catalepsy | 1.88965601 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.86647977 |
| 30 | MP0005310_abnormal_salivary_gland | 1.85433346 |
| 31 | MP0001984_abnormal_olfaction | 1.79046410 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.78635722 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.76705352 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.70242074 |
| 35 | MP0003329_amyloid_beta_deposits | 1.69077272 |
| 36 | MP0005248_abnormal_Harderian_gland | 1.67718616 |
| 37 | MP0004142_abnormal_muscle_tone | 1.66194993 |
| 38 | MP0002572_abnormal_emotion/affect_behav | 1.66065992 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.56448079 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.55190748 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.54507782 |
| 42 | MP0002229_neurodegeneration | 1.53895432 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.52867095 |
| 44 | MP0003879_abnormal_hair_cell | 1.52805324 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.52304034 |
| 46 | MP0002796_impaired_skin_barrier | 1.51290400 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.50110862 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.49874865 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.49407940 |
| 50 | MP0002896_abnormal_bone_mineralization | 1.42778516 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.41833507 |
| 52 | MP0000778_abnormal_nervous_system | 1.40584513 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.40552499 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.40357653 |
| 55 | MP0003633_abnormal_nervous_system | 1.39584529 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.39053002 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.37467437 |
| 58 | MP0001970_abnormal_pain_threshold | 1.37407559 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.35487381 |
| 60 | MP0003632_abnormal_nervous_system | 1.34372363 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.32402886 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.32212526 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.30738084 |
| 64 | MP0008569_lethality_at_weaning | 1.28176292 |
| 65 | MP0003631_nervous_system_phenotype | 1.28137715 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.27629414 |
| 67 | MP0001440_abnormal_grooming_behavior | 1.24166590 |
| 68 | MP0005275_abnormal_skin_tensile | 1.22574793 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.22152483 |
| 70 | MP0004924_abnormal_behavior | 1.22152483 |
| 71 | MP0005409_darkened_coat_color | 1.20976528 |
| 72 | MP0002736_abnormal_nociception_after | 1.19477687 |
| 73 | MP0003303_peritoneal_inflammation | 1.18153110 |
| 74 | MP0003091_abnormal_cell_migration | 1.17632206 |
| 75 | MP0000462_abnormal_digestive_system | 1.16269868 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.16149858 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.15257422 |
| 78 | MP0000383_abnormal_hair_follicle | 1.14892206 |
| 79 | MP0000604_amyloidosis | 1.14395568 |
| 80 | MP0001502_abnormal_circadian_rhythm | 1.14141274 |
| 81 | MP0001501_abnormal_sleep_pattern | 1.14024184 |
| 82 | MP0006082_CNS_inflammation | 1.14020822 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 1.13338502 |
| 84 | MP0008260_abnormal_autophagy | 1.12546452 |
| 85 | MP0004381_abnormal_hair_follicle | 1.11537724 |
| 86 | MP0003300_gastrointestinal_ulcer | 1.11450155 |
| 87 | MP0001963_abnormal_hearing_physiology | 1.10604747 |
| 88 | MP0003787_abnormal_imprinting | 1.08793423 |
| 89 | MP0002882_abnormal_neuron_morphology | 1.08581514 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.08251113 |
| 91 | MP0002693_abnormal_pancreas_physiology | 1.06546662 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 1.05246067 |
| 93 | MP0005410_abnormal_fertilization | 1.04334136 |
| 94 | MP0005257_abnormal_intraocular_pressure | 1.03939774 |
| 95 | MP0003279_aneurysm | 1.03120790 |
| 96 | MP0003172_abnormal_lysosome_physiology | 1.02383907 |
| 97 | MP0000955_abnormal_spinal_cord | 1.02189269 |
| 98 | MP0005408_hypopigmentation | 1.00290170 |
| 99 | MP0001177_atelectasis | 0.97265478 |
| 100 | MP0001188_hyperpigmentation | 0.96970533 |
| 101 | MP0002090_abnormal_vision | 0.96852086 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.95730276 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.93616982 |
| 104 | MP0004510_myositis | 0.92132385 |
| 105 | MP0002133_abnormal_respiratory_system | 0.91074190 |
| 106 | MP0005388_respiratory_system_phenotype | 0.91074190 |
| 107 | MP0004134_abnormal_chest_morphology | 0.91032107 |
| 108 | MP0004484_altered_response_of | 0.90517077 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.90508427 |
| 110 | MP0004147_increased_porphyrin_level | 0.89960216 |
| 111 | MP0008004_abnormal_stomach_pH | 0.89912990 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.88644040 |
| 113 | MP0003868_abnormal_feces_composition | 0.88141402 |
| 114 | MP0005253_abnormal_eye_physiology | 0.87441300 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.86685851 |
| 116 | MP0004264_abnormal_extraembryonic_tissu | 0.86216813 |
| 117 | MP0000371_diluted_coat_color | 0.85666392 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.84120742 |
| 119 | MP0002557_abnormal_social/conspecific_i | 0.83901169 |
| 120 | MP0005535_abnormal_body_temperature | 0.81959747 |
| 121 | MP0005451_abnormal_body_composition | 0.79711775 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.79671058 |
| 123 | MP0001790_abnormal_immune_system | 0.79185240 |
| 124 | MP0005387_immune_system_phenotype | 0.79185240 |
| 125 | MP0005000_abnormal_immune_tolerance | 0.78729715 |
| 126 | MP0004130_abnormal_muscle_cell | 0.77737480 |
| 127 | MP0002295_abnormal_pulmonary_circulatio | 0.76337421 |
| 128 | MP0009840_abnormal_foam_cell | 0.75434119 |
| 129 | MP0003045_fibrosis | 0.74544577 |
| 130 | MP0001851_eye_inflammation | 0.73803107 |
| 131 | MP0002163_abnormal_gland_morphology | 0.71738358 |
| 132 | MP0008874_decreased_physiological_sensi | 0.71467503 |
| 133 | MP0002971_abnormal_brown_adipose | 0.71349527 |
| 134 | MP0002419_abnormal_innate_immunity | 0.70745084 |
| 135 | MP0001542_abnormal_bone_strength | 0.69509606 |
| 136 | MP0000427_abnormal_hair_cycle | 0.68887516 |
| 137 | MP0001849_ear_inflammation | 0.67756311 |
| 138 | MP0000015_abnormal_ear_pigmentation | 0.67339449 |
| 139 | MP0005595_abnormal_vascular_smooth | 0.66970346 |
| 140 | MP0005166_decreased_susceptibility_to | 0.66398648 |
| 141 | MP0002752_abnormal_somatic_nervous | 0.66225973 |
| 142 | MP0006072_abnormal_retinal_apoptosis | 0.64848263 |
| 143 | MP0000681_abnormal_thyroid_gland | 0.64495264 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.64453173 |
| 145 | MP0003075_altered_response_to | 0.64405594 |
| 146 | MP0005503_abnormal_tendon_morphology | 0.63590830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.27901756 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.27901756 |
| 3 | Atonic seizures (HP:0010819) | 4.27827561 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 4.26514451 |
| 5 | Neurofibrillary tangles (HP:0002185) | 3.88100691 |
| 6 | Focal motor seizures (HP:0011153) | 3.65207074 |
| 7 | Akinesia (HP:0002304) | 3.59648937 |
| 8 | Parakeratosis (HP:0001036) | 3.46662869 |
| 9 | Pheochromocytoma (HP:0002666) | 3.46174555 |
| 10 | Neuroendocrine neoplasm (HP:0100634) | 3.28722817 |
| 11 | Abnormality of the corticospinal tract (HP:0002492) | 3.01143073 |
| 12 | Obstructive sleep apnea (HP:0002870) | 2.99340841 |
| 13 | Absent frontal sinuses (HP:0002688) | 2.90852573 |
| 14 | Peripheral hypomyelination (HP:0007182) | 2.89540093 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.89535465 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 2.81278451 |
| 17 | Epileptic encephalopathy (HP:0200134) | 2.73678211 |
| 18 | White forelock (HP:0002211) | 2.58861383 |
| 19 | Retinal dysplasia (HP:0007973) | 2.55820248 |
| 20 | Medial flaring of the eyebrow (HP:0010747) | 2.54143821 |
| 21 | Blue irides (HP:0000635) | 2.53835512 |
| 22 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.53801647 |
| 23 | Onion bulb formation (HP:0003383) | 2.53555118 |
| 24 | Abnormal hair whorl (HP:0010721) | 2.51949442 |
| 25 | Patchy hypopigmentation of hair (HP:0011365) | 2.51163764 |
| 26 | Intention tremor (HP:0002080) | 2.47287255 |
| 27 | Hypothermia (HP:0002045) | 2.45752955 |
| 28 | Hyperventilation (HP:0002883) | 2.44798047 |
| 29 | Increased circulating renin level (HP:0000848) | 2.44532792 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42836191 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.42564911 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.42564911 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.42564911 |
| 34 | Papilledema (HP:0001085) | 2.42072954 |
| 35 | Hypomagnesemia (HP:0002917) | 2.40949605 |
| 36 | Heterochromia iridis (HP:0001100) | 2.40398266 |
| 37 | Papillary thyroid carcinoma (HP:0002895) | 2.40097795 |
| 38 | Vaginal atresia (HP:0000148) | 2.39223431 |
| 39 | Cerebral inclusion bodies (HP:0100314) | 2.39146604 |
| 40 | Cerebral hemorrhage (HP:0001342) | 2.38740839 |
| 41 | Thickened helices (HP:0000391) | 2.37305917 |
| 42 | Slow saccadic eye movements (HP:0000514) | 2.36290354 |
| 43 | Lower limb asymmetry (HP:0100559) | 2.33618546 |
| 44 | Gait imbalance (HP:0002141) | 2.32840868 |
| 45 | Spastic gait (HP:0002064) | 2.31255812 |
| 46 | Truncal ataxia (HP:0002078) | 2.31088792 |
| 47 | Genital tract atresia (HP:0001827) | 2.30561561 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.30541094 |
| 49 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.28477038 |
| 50 | Asymmetry of the thorax (HP:0001555) | 2.28382869 |
| 51 | Congenital primary aphakia (HP:0007707) | 2.28122428 |
| 52 | Macroorchidism (HP:0000053) | 2.26843151 |
| 53 | Dysmetria (HP:0001310) | 2.26451563 |
| 54 | Vascular tortuosity (HP:0004948) | 2.22746541 |
| 55 | Mitral stenosis (HP:0001718) | 2.21255648 |
| 56 | Neuronal loss in central nervous system (HP:0002529) | 2.20627002 |
| 57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.20573650 |
| 58 | Arterial tortuosity (HP:0005116) | 2.18592692 |
| 59 | Hyperparathyroidism (HP:0000843) | 2.17285438 |
| 60 | Dialeptic seizures (HP:0011146) | 2.17162403 |
| 61 | Mutism (HP:0002300) | 2.16204380 |
| 62 | Febrile seizures (HP:0002373) | 2.16167712 |
| 63 | Leukodystrophy (HP:0002415) | 2.16041930 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15097802 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.15097802 |
| 66 | Hypoplasia of the iris (HP:0007676) | 2.14545303 |
| 67 | Deformed sella turcica (HP:0002681) | 2.13365530 |
| 68 | Diminished movement (HP:0002374) | 2.12928564 |
| 69 | Myokymia (HP:0002411) | 2.12595966 |
| 70 | Postural tremor (HP:0002174) | 2.10916300 |
| 71 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10533769 |
| 72 | Testicular neoplasm (HP:0010788) | 2.09157562 |
| 73 | Hypercortisolism (HP:0001578) | 2.08369440 |
| 74 | Symptomatic seizures (HP:0011145) | 2.08089722 |
| 75 | Buphthalmos (HP:0000557) | 2.05818288 |
| 76 | Abnormal auditory evoked potentials (HP:0006958) | 2.04800065 |
| 77 | Scanning speech (HP:0002168) | 2.03553271 |
| 78 | Autoamputation (HP:0001218) | 2.02626567 |
| 79 | Focal seizures (HP:0007359) | 2.00983009 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.00947823 |
| 81 | Dysdiadochokinesis (HP:0002075) | 2.00913109 |
| 82 | Bundle branch block (HP:0011710) | 2.00794384 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.00620638 |
| 84 | Diplopia (HP:0000651) | 1.98923253 |
| 85 | Abnormality of binocular vision (HP:0011514) | 1.98923253 |
| 86 | Ocular albinism (HP:0001107) | 1.98659487 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97105499 |
| 88 | Absence seizures (HP:0002121) | 1.96818598 |
| 89 | Hypoglycemic seizures (HP:0002173) | 1.95525852 |
| 90 | Acute necrotizing encephalopathy (HP:0006965) | 1.94752222 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93950195 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93950195 |
| 93 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93950195 |
| 94 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.93729242 |
| 95 | Cerebral hypomyelination (HP:0006808) | 1.93090971 |
| 96 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.90368635 |
| 97 | Clumsiness (HP:0002312) | 1.90099357 |
| 98 | Fetal akinesia sequence (HP:0001989) | 1.89552873 |
| 99 | Poor speech (HP:0002465) | 1.88508728 |
| 100 | Polydipsia (HP:0001959) | 1.88433689 |
| 101 | Abnormal drinking behavior (HP:0030082) | 1.88433689 |
| 102 | Hypokalemic alkalosis (HP:0001949) | 1.87893951 |
| 103 | Methylmalonic acidemia (HP:0002912) | 1.87800760 |
| 104 | Barrel-shaped chest (HP:0001552) | 1.87480770 |
| 105 | Thin bony cortex (HP:0002753) | 1.87424636 |
| 106 | Ventricular fibrillation (HP:0001663) | 1.87396360 |
| 107 | Nuclear cataract (HP:0100018) | 1.87058934 |
| 108 | Apathy (HP:0000741) | 1.86698666 |
| 109 | Generalized myoclonic seizures (HP:0002123) | 1.86495769 |
| 110 | Metabolic alkalosis (HP:0200114) | 1.86162907 |
| 111 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85284270 |
| 112 | Ankle clonus (HP:0011448) | 1.85137808 |
| 113 | Stomatitis (HP:0010280) | 1.84964158 |
| 114 | Hyporeflexia of lower limbs (HP:0002600) | 1.84893586 |
| 115 | Abnormality of magnesium homeostasis (HP:0004921) | 1.84111556 |
| 116 | Depression (HP:0000716) | 1.83773444 |
| 117 | Abnormality of the frontal sinuses (HP:0002687) | 1.83608082 |
| 118 | Generalized tonic-clonic seizures (HP:0002069) | 1.83228335 |
| 119 | Diminished motivation (HP:0000745) | 1.83041529 |
| 120 | Hepatosplenomegaly (HP:0001433) | 1.82382361 |
| 121 | Torticollis (HP:0000473) | 1.81266664 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 1.80965068 |
| 123 | Curly hair (HP:0002212) | 1.80954317 |
| 124 | Hemiplegia (HP:0002301) | 1.80896989 |
| 125 | Spastic paraparesis (HP:0002313) | 1.80872429 |
| 126 | Interstitial pulmonary disease (HP:0006530) | 1.80850059 |
| 127 | Germ cell neoplasia (HP:0100728) | 1.79424974 |
| 128 | Anteriorly placed anus (HP:0001545) | 1.79262567 |
| 129 | Disinhibition (HP:0000734) | 1.77779311 |
| 130 | Increased serum pyruvate (HP:0003542) | 1.77133961 |
| 131 | Abnormality of glycolysis (HP:0004366) | 1.77133961 |
| 132 | Progressive neurologic deterioration (HP:0002344) | 1.76262791 |
| 133 | Axonal loss (HP:0003447) | 1.75008561 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.74704275 |
| 135 | Insidious onset (HP:0003587) | 1.74661269 |
| 136 | Termporal pattern (HP:0011008) | 1.74661269 |
| 137 | Lower limb muscle weakness (HP:0007340) | 1.74627119 |
| 138 | Muscle fiber splitting (HP:0003555) | 1.74543195 |
| 139 | Menstrual irregularities (HP:0000858) | 1.73824960 |
| 140 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73397158 |
| 141 | Abnormality of renin-angiotensin system (HP:0000847) | 1.72962773 |
| 142 | Action tremor (HP:0002345) | 1.72200337 |
| 143 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.71467954 |
| 144 | Distal lower limb muscle weakness (HP:0009053) | 1.71388927 |
| 145 | Stridor (HP:0010307) | 1.70510801 |
| 146 | Increased cerebral lipofuscin (HP:0011813) | 1.70505713 |
| 147 | Urinary urgency (HP:0000012) | 1.68544561 |
| 148 | Alacrima (HP:0000522) | 1.68111643 |
| 149 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67725730 |
| 150 | Absent/shortened dynein arms (HP:0200106) | 1.67725730 |
| 151 | Abnormality of the fovea (HP:0000493) | 1.66954191 |
| 152 | Abnormal eating behavior (HP:0100738) | 1.66841926 |
| 153 | Urinary incontinence (HP:0000020) | 1.66734175 |
| 154 | Gaze-evoked nystagmus (HP:0000640) | 1.65911145 |
| 155 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.65903360 |
| 156 | Hypoplasia of the fovea (HP:0007750) | 1.65903360 |
| 157 | Overgrowth (HP:0001548) | 1.64683428 |
| 158 | Multiple lipomas (HP:0001012) | 1.64357688 |
| 159 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.63665301 |
| 160 | Abnormal ciliary motility (HP:0012262) | 1.63330524 |
| 161 | Iris hypopigmentation (HP:0007730) | 1.60739330 |
| 162 | Loss of speech (HP:0002371) | 1.60656443 |
| 163 | Rigidity (HP:0002063) | 1.59980169 |
| 164 | Adrenal overactivity (HP:0002717) | 1.59912234 |
| 165 | Dysmetric saccades (HP:0000641) | 1.59702242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.45669485 |
| 2 | OXSR1 | 3.62011257 |
| 3 | TNIK | 3.22563827 |
| 4 | PRPF4B | 3.08633498 |
| 5 | CASK | 2.80416202 |
| 6 | BCR | 2.77476088 |
| 7 | EPHB1 | 2.58395325 |
| 8 | RIPK1 | 2.46362994 |
| 9 | WNK4 | 2.27959420 |
| 10 | PNCK | 2.06609581 |
| 11 | TRIB3 | 2.05210587 |
| 12 | MST4 | 2.00440339 |
| 13 | INSRR | 1.95409228 |
| 14 | PKN1 | 1.94043478 |
| 15 | NEK6 | 1.90293652 |
| 16 | MAPK15 | 1.82626780 |
| 17 | NTRK2 | 1.77829335 |
| 18 | WNK1 | 1.76825091 |
| 19 | MARK1 | 1.75663320 |
| 20 | MAP3K14 | 1.74281480 |
| 21 | BMPR2 | 1.73992466 |
| 22 | MAP3K9 | 1.73526037 |
| 23 | LATS2 | 1.64643756 |
| 24 | CDK19 | 1.57763174 |
| 25 | SGK223 | 1.56461277 |
| 26 | SGK494 | 1.56461277 |
| 27 | PDGFRA | 1.51836838 |
| 28 | AKT3 | 1.49129298 |
| 29 | KSR2 | 1.45897958 |
| 30 | PBK | 1.43789413 |
| 31 | TYRO3 | 1.41538642 |
| 32 | IRAK4 | 1.38003150 |
| 33 | ARAF | 1.36779497 |
| 34 | IRAK1 | 1.33402456 |
| 35 | CAMKK1 | 1.31592565 |
| 36 | UHMK1 | 1.31138675 |
| 37 | FGFR3 | 1.31133847 |
| 38 | RET | 1.30395594 |
| 39 | BMPR1B | 1.24954443 |
| 40 | NTRK1 | 1.21200363 |
| 41 | PDGFRB | 1.20886775 |
| 42 | IRAK2 | 1.20645674 |
| 43 | SCYL2 | 1.18339548 |
| 44 | DDR2 | 1.17844563 |
| 45 | MAP3K2 | 1.16669325 |
| 46 | CAMKK2 | 1.14148440 |
| 47 | MET | 1.14071608 |
| 48 | FGFR2 | 1.10880393 |
| 49 | STK38 | 1.09752680 |
| 50 | CAMK2D | 1.07294819 |
| 51 | MAP3K12 | 1.06115174 |
| 52 | MAPK13 | 1.03482414 |
| 53 | PKN2 | 1.03151892 |
| 54 | DMPK | 1.02671858 |
| 55 | MAP3K6 | 1.02262221 |
| 56 | PRKCE | 1.01679428 |
| 57 | RIPK4 | 1.00743659 |
| 58 | CAMK2B | 0.98394652 |
| 59 | WNK3 | 0.96902172 |
| 60 | RPS6KA2 | 0.96755385 |
| 61 | PRKCQ | 0.95045279 |
| 62 | EPHA4 | 0.93481020 |
| 63 | MAP3K13 | 0.92371304 |
| 64 | TRPM7 | 0.90747414 |
| 65 | TESK1 | 0.90705187 |
| 66 | FGFR4 | 0.90079643 |
| 67 | STK24 | 0.88635278 |
| 68 | MAPKAPK5 | 0.88377098 |
| 69 | GRK7 | 0.87334519 |
| 70 | MOS | 0.86636419 |
| 71 | SGK2 | 0.85944080 |
| 72 | SIK1 | 0.85693255 |
| 73 | ROCK2 | 0.85205706 |
| 74 | PRKD3 | 0.83995660 |
| 75 | NTRK3 | 0.79605780 |
| 76 | MAP2K4 | 0.78786025 |
| 77 | CSNK1A1L | 0.78567323 |
| 78 | CLK1 | 0.78535847 |
| 79 | CSNK1G3 | 0.78489273 |
| 80 | MAP3K3 | 0.78203029 |
| 81 | ERBB4 | 0.77352131 |
| 82 | PRKCH | 0.76946609 |
| 83 | PLK2 | 0.75901406 |
| 84 | CDK5 | 0.75414513 |
| 85 | RPS6KB1 | 0.75036766 |
| 86 | IRAK3 | 0.74998581 |
| 87 | MARK2 | 0.74542553 |
| 88 | PTK6 | 0.74428070 |
| 89 | FGR | 0.74201985 |
| 90 | MAPK12 | 0.73023833 |
| 91 | CAMK2A | 0.71740947 |
| 92 | MAP2K7 | 0.71480198 |
| 93 | PAK6 | 0.70934524 |
| 94 | NEK9 | 0.69989503 |
| 95 | PDPK1 | 0.68022675 |
| 96 | CAMK2G | 0.67247996 |
| 97 | KSR1 | 0.65583278 |
| 98 | MAPK10 | 0.64780378 |
| 99 | PTK2 | 0.63904129 |
| 100 | FRK | 0.63688747 |
| 101 | FER | 0.63681280 |
| 102 | HIPK2 | 0.63314783 |
| 103 | GRK5 | 0.62792560 |
| 104 | PRKD2 | 0.60815850 |
| 105 | MAPKAPK3 | 0.60560000 |
| 106 | CSNK1G1 | 0.60173986 |
| 107 | FES | 0.59249485 |
| 108 | MAP2K1 | 0.57853268 |
| 109 | CSNK1G2 | 0.56697016 |
| 110 | PAK3 | 0.56295165 |
| 111 | IKBKE | 0.53147591 |
| 112 | ADRBK2 | 0.53139822 |
| 113 | SGK3 | 0.53070365 |
| 114 | LATS1 | 0.52097807 |
| 115 | PHKG1 | 0.52076990 |
| 116 | PHKG2 | 0.52076990 |
| 117 | TAOK1 | 0.52070228 |
| 118 | SIK3 | 0.51507913 |
| 119 | DAPK2 | 0.51399054 |
| 120 | MAPK7 | 0.51152520 |
| 121 | PRKG2 | 0.50985641 |
| 122 | YES1 | 0.50839341 |
| 123 | ITK | 0.50456026 |
| 124 | BRAF | 0.50055882 |
| 125 | PDK1 | 0.49712956 |
| 126 | JAK2 | 0.49676392 |
| 127 | MUSK | 0.49009795 |
| 128 | EEF2K | 0.48994577 |
| 129 | EPHA3 | 0.48016312 |
| 130 | IKBKB | 0.47505503 |
| 131 | ROCK1 | 0.47030798 |
| 132 | LIMK1 | 0.47016516 |
| 133 | CDK6 | 0.45799256 |
| 134 | TXK | 0.45757115 |
| 135 | ICK | 0.45725388 |
| 136 | FYN | 0.45584898 |
| 137 | PINK1 | 0.44947598 |
| 138 | CSNK1A1 | 0.44696309 |
| 139 | MAP3K1 | 0.44332619 |
| 140 | SGK1 | 0.43027650 |
| 141 | MINK1 | 0.41640099 |
| 142 | CSK | 0.41585823 |
| 143 | PRKG1 | 0.41059570 |
| 144 | TAOK3 | 0.39532578 |
| 145 | GSK3A | 0.39421136 |
| 146 | PRKACA | 0.38066280 |
| 147 | PIK3CA | 0.37621056 |
| 148 | PRKCG | 0.36656615 |
| 149 | JAK1 | 0.36127866 |
| 150 | PRKD1 | 0.35380783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.21365579 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.98896272 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.74754856 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.53797284 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.39199099 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.32864115 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.28376018 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.22038786 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09486510 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.07814246 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.06220724 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02867295 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.98210718 |
| 14 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.79689060 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.69216248 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.59671067 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.55109831 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.53239531 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51908680 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.51466044 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46274699 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.45146840 |
| 23 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.43803615 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.43005320 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43001553 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.40932252 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.29407554 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25716408 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24581447 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.20472281 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18673478 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18350636 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18190419 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17686882 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15638425 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15333840 |
| 37 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10602524 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.10079073 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.08070872 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08042620 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07909429 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05617011 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03231769 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02796364 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.02774317 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01772822 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.01682706 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01640553 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.99509725 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99420494 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.98110581 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98088461 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94541687 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92638019 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92516982 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90864154 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.89873814 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88520358 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88303790 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87885592 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86373150 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 0.86227478 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85069402 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84981523 |
| 65 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84129925 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83626132 |
| 67 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83433382 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82925689 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.79909255 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79332531 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.79091765 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77707405 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76977767 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75388471 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74886244 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74605971 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74589866 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.73850751 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73602212 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73407144 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72736955 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72408660 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71246367 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69964908 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69471561 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.68810803 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68685978 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.67964122 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67382993 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67334305 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65918934 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65791956 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65761609 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65483635 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64469086 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63280969 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62812243 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62397446 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62311036 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62309217 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.60778193 |
| 102 | Phototransduction_Homo sapiens_hsa04744 | 0.60591505 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.59929781 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59904361 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59668855 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59590376 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59566782 |
| 108 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59482585 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.59126108 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59101046 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58880507 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58683388 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58521044 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58048411 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.56604789 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56513065 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55799799 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54716764 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53949496 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52932094 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52816682 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52405304 |
| 123 | Allograft rejection_Homo sapiens_hsa05330 | 0.51858913 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50163999 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50118386 |
| 126 | Malaria_Homo sapiens_hsa05144 | 0.49624598 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.49021610 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.47890167 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.46571440 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46278555 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45328895 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44320529 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44177583 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43448783 |
| 135 | Tuberculosis_Homo sapiens_hsa05152 | 0.42480154 |
| 136 | Pertussis_Homo sapiens_hsa05133 | 0.41036838 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40958259 |
| 138 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39792623 |
| 139 | Asthma_Homo sapiens_hsa05310 | 0.39003373 |
| 140 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38219757 |
| 141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36024128 |
| 142 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35109253 |
| 143 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31985677 |
| 144 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31255892 |
| 145 | Tight junction_Homo sapiens_hsa04530 | 0.31239186 |
| 146 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30939841 |
| 147 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28280816 |

